FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

Alnylam Shares Skyrocket on Clinical Study Results - Biotech Movers

Alnylam Shares Skyrocket on Clinical Study Results - Biotech Movers

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Five Sneaky Tactics North Korea Uses To Beat United Nations Sanctions

Five Sneaky Tactics North Korea Uses To Beat United Nations Sanctions

Ultragenyx Makes Bid for Dimension Therapeutics - Biotech Movers

Ultragenyx Makes Bid for Dimension Therapeutics - Biotech Movers

Bristol-Myers Squibb Stock Still a Beast?

Bristol-Myers Squibb Stock Still a Beast?

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Teva's New CEO Brings This Secret Weapon

Teva's New CEO Brings This Secret Weapon

FDA Approves First 'Biosimilar' for Cancer Treatment

FDA Approves First 'Biosimilar' for Cancer Treatment